KaliVir Immunotherapeutics, Inc., a biotechnology company developing cutting-edge, multi-mechanism oncolytic virus immunotherapy programs
India, being the prominent manufacturing hub for pharmaceuticals catering to the medicinal needs of the global population
The approval to shift manufacturing to their own facilities at the existing retail price has been granted
The FDA has given its approval for Tibsovo (ivosidenib) to be used in the treatment of adult patients
Celltrion USA announced that the US Food and Drug Administration (FDA) has approved
Researchers at the Indian Institute of Science Education and Research Bhopal, also known as IISER
The US Food and Drug Administration (FDA) has accepted AstraZeneca's Supplemental Biologics
The Department of Pharmaceuticals (DoP) has made changes to the operational guidelines for the pharmaceutical production
FluMist, AstraZeneca's nasal spray flu vaccination that has been on the market for two decades, might be ready for self-administration as soon as next year.
Torrent Pharmaceuticals Ltd recorded a consolidated net profit of 386 crore for the September quarter, up 24% from the previous year, while revenue increased 16% from 2,291 crore to 2,660 crore. Its earnings before interest, taxes, depreciation...